A 5% weight loss over 2 years in patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer was associated with worse outcomes, according to new research that investigated the body mass index (BMI) data of these patients.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045